Engineered immune cells take aim at brain tumors
NCT ID NCT07656103
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests a new cell therapy called QH101 for people with solid tumors that have spread to the brain, spinal cord, or surrounding membranes. The therapy uses specially engineered immune cells designed to better recognize and attack cancer cells. The main goals are to check safety, find the right dose, and see if it can help control the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- QH101 cell injection (engineered immune cells)
- What this could lead to
- If successful, this could offer a new treatment option for people with hard-to-treat brain or spinal cord metastases.
- What could go wrong
- This is a very early, small study (7 people) testing safety and dosing. The therapy may not work or could cause serious side effects like cytokine release syndrome.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100021, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict frailty in serious illness? a large study investigates
- Could targeted drugs spare brain cancer patients from radiation after surgery?
- Study reveals why immunotherapy works differently in liver, lung, and brain tumors
- Could a common pain pill protect the brain during surgery?
- Promising new combo targets hard-to-treat breast cancer brain tumors
- Immune cells injected into brain to fight tumors